MUNC13.4-CD34 suspension, MUNC13.4-T3 suspension
APHP240201
Phase 1 small_molecule active
Quick answer
MUNC13.4-CD34 suspension, MUNC13.4-T3 suspension for Familial Hemophagocytic Lymphohistiocytosis (FHL) is a Phase 1 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pari Pharma GmbH
- Indication
- Familial Hemophagocytic Lymphohistiocytosis (FHL)
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active